109 results
Page 3 of 6
6-K
EX-99.1
nb5wte
19 Jan 22
Jyseleca®▼ (Filgotinib) Licensed for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis In Great Britain
11:37am
6-K
EX-99.1
eb6 njia7a4p7
17 Nov 21
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
6:00am
6-K
EX-99.2
hrqb7vk2
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.1
6io51q1qw7 e8
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
S-8
EX-99.1
9f7rsb8 tgjde3d
26 Oct 21
Registration of securities for employees
4:07pm
S-8
EX-99.2
59noirm wfv
26 Oct 21
Registration of securities for employees
4:07pm
S-8
EX-4.1
ih0 rsiwz2dlw379b
26 Oct 21
Registration of securities for employees
4:07pm
6-K
EX-99.1
2im4 px82xp
6 Oct 21
Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
6:00am
6-K
EX-99.1
vxzwq2biru26vg 1y
6 Oct 21
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
6:00am
6-K
EX-99.1
7kmin
20 Sep 21
Current report (foreign)
9:26am
6-K
EX-99.2
25gd39d
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
rrxzr4ootvmd n0t0r
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
ntai5vs0
12 Jul 21
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress
9:02am
6-K
EX-99.1
1s9f oinbih
23 Jun 21
Galapagos announces departure of CSO Piet Wigerinck later this year
6:00am
6-K
EX-99.1
09ab 0luhknehgghb
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
EX-99.1
5v1l myvp
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.2
h5w4 uf7o5upil
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.3
2kgbxp2qp2x dgvy9
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
rvdro wqf7s
9 Apr 21
Extension of lock-up period in Gilead-Galapagos collaboration agreement
6:00am
6-K
EX-99.1
sqc8bac45 o8t6co2
25 Mar 21
Galapagos appoints Bart Filius as President and Chief Operating Officer
6:00am